EU cross-border healthcare directive will have fundamental impact on medtech industry
This article was originally published in RAJ Devices
The EU's directive on the application of patients' rights in cross-border healthcare will have a fundamental impact on the medtech market of the future1,2. New structures created by the directive will particularly affect the areas of health technology assessment, e-health and the co-ordination of healthcare specialisations, particularly for rare diseases.
You may also be interested in...
Where are the biggest challenges for notified bodies and manufacturers now there is some experience with the MDR, and can the sector manage the new regulatory requirements successfully?
The European Commission has finally published detailed guidance on the EU IVDR’s classification rules. The IVDR’s completely new classification regime means guidance is urgently needed.
Do you know how to avoid the pitfalls when it comes to clinical evidence under the MDR? Or whether evidence gathered outside the US counts? Amie Smirthwaite of Maetrics answers these and other pivotal questions in this third and final part of an interview series with Medtech Insight.